<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Genes &amp; Cells</journal-id><journal-title-group><journal-title xml:lang="en">Genes &amp; Cells</journal-title><trans-title-group xml:lang="ru"><trans-title>Гены и Клетки</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Genes and Cells</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-1829</issn><issn publication-format="electronic">2500-2562</issn><publisher><publisher-name xml:lang="en">Human Stem Cells Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">217718</article-id><article-id pub-id-type="doi">10.23868/gc217718</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original Study Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Bone marrow transplantation to mice with an experimental model of tuberculosis</article-title><trans-title-group xml:lang="ru"><trans-title>Трансплантация костного мозга мышам с экспериментальной моделью туберкулеза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Isaev</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Исаев</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>redaktor@celltranspl.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pospelov</surname><given-names>L. E.</given-names></name><name xml:lang="ru"><surname>Поспелов</surname><given-names>Л. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>redaktor@celltranspl.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bocharova</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Бочарова</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>redaktor@celltranspl.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Hegert</surname><given-names>V. Ya.</given-names></name><name xml:lang="ru"><surname>Гегерт</surname><given-names>В. Я.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>redaktor@celltranspl.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Stankov</surname><given-names>D. S.</given-names></name><name xml:lang="ru"><surname>Станков</surname><given-names>Д. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>redaktor@celltranspl.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Prikhodko</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Приходько</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>redaktor@celltranspl.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Avdienko</surname><given-names>V. G.</given-names></name><name xml:lang="ru"><surname>Авдиенко</surname><given-names>В. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>redaktor@celltranspl.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pospelov</surname><given-names>A. L.</given-names></name><name xml:lang="ru"><surname>Поспелов</surname><given-names>А. Л.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>redaktor@celltranspl.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">JSC "Institute of Human Stem Cells"</institution></aff><aff><institution xml:lang="ru">ОАО «Институт стволовых клеток человека»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">GU Central Research Institute of Tuberculosis of the Russian Academy of Medical Sciences</institution></aff><aff><institution xml:lang="ru">ГУ Центральный научно-исследовательский институт туберкулеза РАМН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2006-02-15" publication-format="electronic"><day>15</day><month>02</month><year>2006</year></pub-date><volume>1</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>51</fpage><lpage>54</lpage><history><date date-type="received" iso-8601-date="2023-02-11"><day>11</day><month>02</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-02-11"><day>11</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2006, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2006, Эко-Вектор</copyright-statement><copyright-year>2006</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://genescells.ru/2313-1829/article/view/217718">https://genescells.ru/2313-1829/article/view/217718</self-uri><abstract xml:lang="en"><p>The effectiveness of the use of bone marrow cells (CMC) in the treatment of experimental tuberculosis was investigated. It was shown that transplantation of allogeneic bone marrow cells from AKR mice resistant to tuberculosis to C57BL/6 mice sensitive to tuberculosis and infected with mycobacterium strain H37Rv significantly prolonged the life of infected experimental animals and reduced the number of mycobacteria seeded from organs compared with untreated animals. The study of humoral immunity showed that the introduction of allogeneic bone marrow cells leads to nonspecific polyisotypic stimulation of anti-tuberculosis antibodies, which is important in creating a protective humoral background. There was also a pronounced production of IgG2a antibodies in comparison with the level of IgG1 antibodies during therapy with bone marrow cells, which indicates the presence of a Tb1 response, which is clearly protective in tuberculosis. A high level of IgG2a antibodies correlated with a high level of a specific cellular immune response, assessed by a delayed-type hypersensitivity reaction (HRT).</p></abstract><trans-abstract xml:lang="ru"><p>Исследовали эффективность применения клеток костного мозга (ККМ) в лечении экспериментального туберкулеза. Было показано, что трансплантация аллогенных клеток костного мозга от мышей линии AKR, резистентных к туберкулезу, мышам линии C57BL/6, чувствительным к туберкулезу и зараженным микобактериями штамма H37Rv, позволила значительно продлить жизнь зараженным экспериментальным животным и уменьшить число микобактерий, высеваемых из органов, по сравнению с нелеченными животными. Изучение гуморального иммунитета показало, что введение аллогенных клеток костного мозга приводит к неспецифической полиизотипической стимуляции противотуберкулезных антител, что важно в создании протективного гуморального фона. Также была обнаружена выраженная выработка IgG2a антител в сравнении с уровнем IgG1 антител при терапии клетками костного мозга, которая указывает на наличие Тб1-ответа, который носит при туберкулезе явный протективный характер. Высокий уровень IgG2a антител коррелировал с высоким уровнем специфического клеточного иммунного ответа, оцениваемого по реакции гиперчувствительности замедленного типа (ГЗТ).</p></trans-abstract><kwd-group xml:lang="en"><kwd>tuberculosis</kwd><kwd>bone marrow</kwd><kwd>antibodies</kwd><kwd>immunity</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>туберкулез</kwd><kwd>костный мозг</kwd><kwd>антитела</kwd><kwd>иммунитет</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Krishanan A. et al. Durable remission with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood 2005; 105(2): 874-8.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Lane H.C. et al. Syngenic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with ridovudine in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 1990; 113: 512.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Авербах М.М., Мороз А.М.,. Апт А.С., Никоненко В.В. Иммуногенетика инфекционных заболеваний. М., Медицина; 1985.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Gros P., Skamene E., Forget A. Genetic control of natural resistance of mycobacterium bovis (BCG) in mice. J. Immunol. 1981; 127: 2417-21.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Schwebach J.R., Casadevall A, Schneerson R. et al. Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo. Infect. Immun. 2001; 69(9): 5671-8.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Hovav A.H., Fishman Y., Bercovier H. Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine. Infect. Immun. 2005; 73(1): 250-7.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Wang Q.M., Sun S.H., Hu Z.L. et al. Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting. Vaccine 2004; 22(27-28): 3622-7.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Williams A., Reljic R., Naylor I. et al. Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs. Immunology 2004; 111 (3): 328-33.</mixed-citation></ref></ref-list></back></article>
